GenomOncology is a Cleveland-based company with a leading precision medicine platform that currently serves major cancer centers, molecular laboratories and other organizations active in precision medicine. Our platform rests on our extensive AI stack for precision medicine. It houses our complete set of annotations, ontologies, and assertions to create a cross-functional platform of products that are end-to-end: from helping pathologists analyze data coming out of sequencers to the bedside where oncologists make treatment decisions.